Teva CFO Sells $11.6M in Stock
TEVA PHARMACEUTICAL INDUSTRIES LTD
Subscribe to track TEVA
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
TEVA Insider Sale Insider: Kalif Eliyahu Sharon (EVP, Chief Financial Officer) Transaction: Sold 345,810 shares at ~$33.64 Total Value: ~$11.63 Million Remaining Shares: 57,478 Note: Executed under Rule 10b5-1 plan.
Comprehensive Analysis
Significant Insider Sale at Teva Pharmaceutical Industries Ltd (TEVA)
On February 26, 2026, Eliyahu Sharon Kalif, the company's EVP and Chief Financial Officer, sold 345,810 Ordinary Shares at a weighted average price of $33.6448. The total value of the transaction stands at approximately $11.63 million.
Key Details:
- Transaction: Sale (Code S)
- Volume: 345,810 shares
- Post-Transaction Holdings: 57,478 shares
- Plan: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on November 26, 2025.
This transaction represents a substantial reduction in the CFO's direct holdings.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.